相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aqua-(2-formylbenzoato)triphenyltin(IV) induces cell cycle arrest and apoptosis in hypoxic triple negative breast cancer cells
Virendra Singh et al.
TOXICOLOGY IN VITRO (2023)
Intracellular pH-mediated induction of apoptosis in HeLa cells by a sulfonamide carbonic anhydrase inhibitor
Ismail Koyuncu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
Anke Nijhuis et al.
NATURE COMMUNICATIONS (2022)
Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
Anna Maria Buccoliero et al.
GENES (2022)
The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models
Silvia A. Teixeira et al.
VETERINARY SCIENCES (2022)
Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides
Cem Yamali et al.
BIOORGANIC CHEMISTRY (2021)
Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells
Ebru Temiz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth
Silvia A. Teixeira et al.
MOLECULAR NEUROBIOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Hypoxia Induced by Cobalt Chloride Triggers Autophagic Apoptosis of Human and Mouse Drug-Resistant Glioblastoma Cells through Targeting the PI3K-AKT-mTOR Signaling Pathway
Yuan-Wen Lee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Nathaniel H. Boyd et al.
THERANOSTICS (2021)
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance
Masoud Najafi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Hypoxia Inducible Factors' Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches
Quentin Fuchs et al.
CANCERS (2020)
The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
Joonas Haapasalo et al.
CANCERS (2020)
How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH
Shen-Han Lee et al.
CANCERS (2020)
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Chandra B. Mishra et al.
MEDICINAL RESEARCH REVIEWS (2020)
Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
Ismail Koyuncu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Multivalent Carbonic Anhydrases Inhibitors
Fabrizio Carta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
The use of cobalt chloride as a chemical hypoxia model
Jorge Munoz-Sanchez et al.
JOURNAL OF APPLIED TOXICOLOGY (2019)
CoCl2 simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis
Nishant Kumar Rana et al.
BIOLOGICAL RESEARCH (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Rita Assi et al.
CANCER (2018)
Apoptosis: A Target for Anticancer Therapy
Claire M. Pfeffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells
Yasin Tuluce et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2018)
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
Hideaki Abe et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Targeting BCL-2 regulated apoptosis in cancer
Kirsteen J. Campbell et al.
OPEN BIOLOGY (2018)
National cancer database analysis of outcomes in pediatric glioblastoma
Meng Liu et al.
CANCER MEDICINE (2018)
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018)
Alessio Nocentini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Martina Da Ros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Carbonic Anhydrases: Role in pH Control and Cancer
Mam Y. Mboge et al.
METABOLITES (2018)
Precision Medicine in Pediatric Neurooncology: A Review
Aaron Y. Mochizuki et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition
Aurelia Nguyen et al.
ONCOTARGET (2017)
The Role of Hypoxia in Glioblastoma Invasion
Ana Rita Monteiro et al.
CELLS (2017)
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
Katarzyna Stepien et al.
MEDICAL ONCOLOGY (2016)
The hypoxia-mimetic agent CoCl2 induces chemotherapy resistance in LOVO colorectal cancer cells
Guanglei Yang et al.
MOLECULAR MEDICINE REPORTS (2016)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Caroline Wigerup et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Joanna Kopecka et al.
ONCOTARGET (2015)
Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
Daniela Rizzo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Molecular Insights into Pediatric Brain Tumors Have the Potential to Transform Therapy
Amar Gajjar et al.
CLINICAL CANCER RESEARCH (2014)
Advances in the Management of Paediatric High-Grade Glioma
Jenny Adamski et al.
CURRENT ONCOLOGY REPORTS (2014)
Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors
Olga Sedlakova et al.
FRONTIERS IN PHYSIOLOGY (2014)
Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety
Kalyan K. Sethi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
Yoichi Ozawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Function of carbonic anhydrase IX in glioblastoma multiforme
Martin A. Proescholdt et al.
NEURO-ONCOLOGY (2012)
Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies
Elena Soto et al.
INVESTIGATIONAL NEW DRUGS (2011)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells
Fabio Cianchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
CoCl2 Induces Apoptosis via the 18 kDa Translocator Protein in U118MG Human Glioblastoma Cells
Sivan Zeno et al.
BIOCHEMISTRY (2009)
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Johanna Chiche et al.
CANCER RESEARCH (2009)
Therapeutic Applications of Glycosidic Carbonic Anhydrase Inhibitors
Jean-Yves Winum et al.
MEDICINAL RESEARCH REVIEWS (2009)
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
Patrick J. Pollard et al.
BIOCHEMICAL JOURNAL (2008)
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
Chia-Ling Chen et al.
BLOOD (2008)
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin
Anthe S. Zandvliet et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas
Joonas Haapasalo et al.
NEURO-ONCOLOGY (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
A phase I and pharmacokinetic study of indisulam in combination with carboplatin
C. Dittrich et al.
BRITISH JOURNAL OF CANCER (2007)
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Anne Thiry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors
A Cecchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Anticancer and antiviral sulfonamides
A Scozzafava et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)
C van Kesteren et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo
Y Ozawa et al.
EUROPEAN JOURNAL OF CANCER (2001)
Treatment resistance of solid tumors - Role of hypoxia and anemia
P Vaupel et al.
MEDICAL ONCOLOGY (2001)
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells
K Fukuoka et al.
INVESTIGATIONAL NEW DRUGS (2001)
分享论文
